Open Beta
TREN
MetriLume
TREN

US marketsBTCY

SEC-sourced researchBeta

BTCY

BIOTRICITY INC.

Company comparison ↗

Data passport

CIK
0001630113
Exchange
OTC
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Oct 7, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: March 2025: 13,790,294.0000 USD; March 2026: 15,998,239.0000 USD16M USD0 USD0March 2025March 2026
BTCY · Exact amounts and source periods · USD
Period endRevenueFiling date
March 202513,790,294.0000Jul 14, 2026
March 202615,998,239.0000Jul 14, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
March 202615,998,239.0000-2,404,139.0000-718,955.00006,446,488.000039,408,954.0000Jul 14, 2026
March 202513,790,294.0000-8,421,179.0000-2,380,177.00005,640,954.000035,655,054.0000Jul 14, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$16MMarch 2026Jul 14, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$13.79MMarch 2025Jul 14, 202610-K
Net incomeNetIncomeLoss-$2.4MMarch 2026Jul 14, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$718.96KMarch 2026Jul 14, 202610-K
Total assetsAssets$6.45MMarch 2026Jul 14, 202610-K
Total liabilitiesLiabilities$39.41MMarch 2026Jul 14, 202610-K

New filings

Explore methodology ↗